This information was published on 2023-02-06T08:55:51 for IP Right Registration Published.
Field | Value |
(210) | 2315275 (IR 1696690) |
(220) |
24 May 2022
|
(300) |
AT, 30 Nov 2021, AM 13039/2021
|
(511) (510) |
Class 42
Research and development services and scientific advice in the field of pharmaceuticals and diagnostics relating to alzheimer' s disease and dementia; clinical research for others in the field of pharmaceuticals and diagnostics relating to alzheimer' s disease and dementia. Class 44 Providing medical and health information in the field of Alzheimer' s disease and dementia. |
(540) | ADVANTAGE THERAPEUTICS |
(550) | Word |
(730) |
ADvantage Therapeutics GmbH
|
Find out more about publications on the About page.